How do you wean someone off Ativan (lorazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weaning Protocol for Ativan (Lorazepam)

To safely wean a patient from Ativan (lorazepam), implement a gradual tapering schedule of 10-20% dose reduction every 24-48 hours to prevent withdrawal symptoms, with the exact rate determined by duration of use and total daily dose. 1

Assessment of Withdrawal Risk

  • Determine if the patient is at risk for withdrawal based on duration of use:

    • Use < 7 days: Generally can discontinue quickly with minimal risk of withdrawal 2
    • Use between 7-14 days: May need tapering but can be weaned more quickly 2
    • Use > 14 days: Will require a more gradual tapering protocol 2
  • Monitor for signs of benzodiazepine withdrawal, which may include:

    • Anxiety, irritability, insomnia, tremor, headache, dizziness, tachycardia, hypertension, nausea, vomiting, and perceptual disturbances 1
    • More severe symptoms can include seizures, psychosis, and delirium 1

Tapering Protocol

For Short-Term Use (7-14 days)

  • Reduce dose by 20% every 24-48 hours 2
  • Monitor for withdrawal symptoms during each reduction 2

For Long-Term Use (>14 days)

  • Develop a more gradual tapering schedule:
    • Aim to complete withdrawal in less than 6 months to avoid making the withdrawal process the focus of the patient's existence 3
    • Reduce dose by 10-20% of the original dose every 24-48 hours 2

Specific Lorazepam Tapering Strategy

  1. Calculate the total daily dose of lorazepam 2
  2. Divide the calculated dose into 4 doses given every 6 hours 2
  3. Wean lorazepam by 10-20% per day 2
  4. The dosage interval can also be gradually increased:
    • From every 6 hours → every 8 hours → every 12 hours → every 24 hours → every other day before discontinuation 2

Management During Withdrawal

  • Closely monitor for withdrawal symptoms during the tapering process 2

  • If withdrawal symptoms occur:

    • Administer the planned dose from the weaning schedule 2
    • Consider slowing the tapering rate if symptoms are severe 2
  • Adjunctive medications that may help manage withdrawal symptoms:

    • Clonidine, gabapentin, or dexmedetomidine may be used to decrease withdrawal symptoms 2
    • Antidepressants may be helpful if the patient is depressed before or during withdrawal 3

Special Considerations

  • Avoid abrupt discontinuation as it can precipitate life-threatening withdrawal reactions including seizures 1

  • Higher risk patients for severe withdrawal include:

    • Those taking higher doses
    • Those with longer duration of use
    • Elderly patients
    • Patients with history of seizures 1
  • Consider behavioral interventions to support the tapering process:

    • Cognitive-behavioral therapy has shown effectiveness in preventing relapse 3
    • Sleep hygiene education and anxiety management techniques 2

Common Pitfalls to Avoid

  • Tapering too quickly, which can precipitate withdrawal symptoms 1

  • Substituting one dependency for another 3

  • Failing to monitor for protracted withdrawal syndrome, which can persist for weeks to more than 12 months 1

  • Not recognizing that withdrawal symptoms may be confused with re-emergence of the original symptoms for which lorazepam was prescribed 1

  • For patients on multiple sedatives or opioids, develop strategies to wean one medication at a time rather than attempting to wean from both simultaneously 2

Remember that successful withdrawal is associated with improved cognitive and psychomotor functioning, particularly in elderly patients 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.